Healthcare Companies Focusing on Liver Diseases

U.S. Exchanges

List of Publicly Traded Healthcare Companies Focusing on Liver Diseases Listed on Major U.S. Exchanges

The publicly traded companies on this list are biotech, medical device, pharmaceutical or other healthcare companies that provide products relating to the liver. It is very common for companies on this list to provide products and services in other healthcare areas in addition to providing products and treatments for the liver.

Resources:

Additional publicly traded healthcare companies and healthcare categories can be accessed through the link below:

List of Publicly Traded Healthcare Companies

A comparison widget that shows trend, earnings per share (EPS), P/E ratio and beta for each of the companies on this list can be accessed through the link below.

Liver Treatment Industry Comparison Widget

Select the company’s link to access charts, news links and company website and social media information.

Liver: Mid-Cap Stocks

Intercept Pharmaceuticals, Inc. (ICPT) (Biopharmaceutical company: orphan and more prevalent liver diseases)

Liver: Small-Cap Stocks

Enanta Pharmaceuticals, Inc. (ENTA) (Small molecule drugs for viral infections and liver diseases)

FibroGen, Inc. (FGEN) (Biopharmaceutical company: anemia in chronic kidney disease, liver fibrosis, pancreatic cancer, corneal blindness)

Liver: Micro-Cap Stocks

Albireo Pharma, Inc. (ALBO) (orphan pediatric liver diseases and GI disorders)

Arbutus Biopharma Corporation (ABUS) (Canada, biopharmaceutical company: chronic hepatitis B infection)

Arrowhead Research Corporation (ARWR) (Biopharmaceutical company: RNAi therapeutics, chronic hepatitis B infection)

Assembly Biosciences, Inc. (ASMB) (Biopharmaceutical company: treatments for hepatitis B virus infection and C. difficile-associated diarrhea)

Conatus Pharmaceuticals Inc. (CNAT) (Medicines to treat liver disease)

Dicerna Pharmaceuticals, Inc. (DRNA) (Biopharmaceutical company: inherited diseases of the liver and genetically defined cancers)

Dimension Therapeutics Inc. (DMTX) (IPO in October 2015: Gene therapy platform company: rare diseases associated with the liver)

Madrigal Pharmaceuticals, Inc. (MDGL) (Cardiovascular, liver and metabolic diseases)

Ocera Therapeutics, Inc. (OCRX) (Biopharmaceutical company: acute and chronic liver disease)

Vital Therapies, Inc. (VTL) (Cell-based system for the treatment of acute liver failure)

Liver: Nano-Cap Stocks

Biostar Pharmaceuticals, Inc. (BSPM) (China: manufacturer of pharmaceutical and health supplement products; over-the-counter medicine for chronic hepatitis B)

Galmed Pharmaceuticals Ltd. (GLMD) (Israel, biopharmaceutical company: oral therapy for treating liver diseases and cholesterol gallstones)

Phaserx, Inc. (PZRX) (IPO May, 18 2016: biopharmaceutical company focused on treatments for enzyme deficiencies in the liver)

Related Links:

List of Pharmaceutical Companies

List of Biotech Companies

Publicly Traded Companies by Sector and Industry